Biolase: Funding, Investors & Team (Sep 2026)
Dental specialists and dentists can execute a variety of minimally invasive dental operations with the use of BIOLASE, Inc.'s unique dental laser systems, which are manufactured and marketed globally. These procedures include cosmetic, restorative, and surgical ones. For many common dental treatments, BIOLASE's laser systems are intended to deliver clinically superior, patient-friendly outcomes than may be attained with conventional tools. Up to this point, BIOLASE has sold over 36,200 laser systems in more than 90 different nations.
Biolase has raised $28.3M across 5 funding rounds on record, the most recent an undisclosed round of $7.0M announced in Feb 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Biolase Company Profile and Key Stats
Latest funding round on record: Feb 2024.
Biolase Funding Rounds
Biolase raised $6.5M in a Post-IPO Equity announced in Jun 2022.
7 months later, an undisclosed round of $5.8M was announced in Jan 2023.
4 months later, an undisclosed round of $4.5M was announced in May 2023.
4 months later, an undisclosed round of $4.5M was announced in Sep 2023.
5 months later, an undisclosed round of $7.0M was announced in Feb 2024.
Biolase Founders and Leadership Team
No contact details are on record for this team yet.
Biolase Funding Compared to Other Biotechnology Startups
Biolase's latest round of $7.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Biolase in Biotechnology and Irvine
Companies Similar to Biolase
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
Biolase Funding FAQs
What does Biolase do?
Dental specialists and dentists can execute a variety of minimally invasive dental operations with the use of BIOLASE, Inc.'s unique dental laser systems, which are manufactured and marketed globally. These procedures include cosmetic, restorative, and surgical ones. For many common dental treatments, BIOLASE's laser systems are intended to deliver clinically superior, patient-friendly outcomes than may be attained with conventional tools. Up to this point, BIOLASE has sold over 36,200 laser systems in more than 90 different nations.
How much funding has Biolase raised?
Biolase has raised $28.3M across 5 rounds on record. The most recent is an undisclosed round of $7.0M announced in Feb 2024.
When did Biolase last raise funding?
Biolase's most recent funding round on record is an undisclosed round of $7.0M, announced in Feb 2024.
Who founded Biolase?
FundedIQ lists Michael Reyes (Founder) at Biolase.
Who is the CEO of Biolase?
Jake Philip is listed as CEO at Biolase.
Where is Biolase headquartered?
Biolase is based in Irvine, California, United States.
How many employees does Biolase have?
Biolase is in the 251-500 employee band.
How does Biolase's funding compare to other Biotechnology startups?
Biolase's latest round of $7.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Biolase Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biolase is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.